CCR5 and renal fibrosis: In conclusion, our study demonstrated that in vitro- and in vivo-induced MDSCs alleviate renal fibrosis similarly, both by promoting the CCL5–CCR5 axis interaction and TGF-β1/Smad/Snail signaling pathway inhibition.